$SLXP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SALIX PHARMACEUTICALS LTD.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in SALIX PHARMACEUTICALS LTD. Get notifications about new insider transactions in SALIX PHARMACEUTICALS LTD for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 06 2007 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Sell | S | 12.33 | 400 | 4,932 | 59,885 | 60.3 K to 59.9 K (-0.66 %) |
Jul 06 2007 | SLXP | SALIX PHARMACEUTIC ... | KEANE WILLIAM P | Director | Sell | S | 12.29 | 1,300 | 15,977 | 17,763 | 19.1 K to 17.8 K (-6.82 %) |
Jul 06 2007 | SLXP | SALIX PHARMACEUTIC ... | KEANE WILLIAM P | Director | Sell | S | 12.30 | 1,667 | 20,504 | 19,063 | 20.7 K to 19.1 K (-8.04 %) |
Jul 06 2007 | SLXP | SALIX PHARMACEUTIC ... | KEANE WILLIAM P | Director | Sell | S | 12.31 | 300 | 3,693 | 20,730 | 21 K to 20.7 K (-1.43 %) |
Jul 06 2007 | SLXP | SALIX PHARMACEUTIC ... | KEANE WILLIAM P | Director | Sell | S | 12.33 | 200 | 2,466 | 21,030 | 21.2 K to 21 K (-0.94 %) |
Jul 06 2007 | SLXP | SALIX PHARMACEUTIC ... | Forbes William P | V.P. Research& Deve ... | Sell | S | 12.31 | 100 | 1,231 | 26,232 | 26.3 K to 26.2 K (-0.38 %) |
Jul 06 2007 | SLXP | SALIX PHARMACEUTIC ... | Forbes William P | V.P. Research& Deve ... | Sell | S | 12.33 | 1,013 | 12,490 | 26,332 | 27.3 K to 26.3 K (-3.70 %) |
Jul 06 2007 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Sell | S | 12.29 | 1,300 | 15,977 | 45,001 | 46.3 K to 45 K (-2.81 %) |
Jul 06 2007 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Sell | S | 12.30 | 1,029 | 12,657 | 46,301 | 47.3 K to 46.3 K (-2.17 %) |
Jul 06 2007 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Sell | S | 12.31 | 400 | 4,924 | 47,330 | 47.7 K to 47.3 K (-0.84 %) |
Jul 06 2007 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Sell | S | 12.32 | 300 | 3,696 | 47,730 | 48 K to 47.7 K (-0.62 %) |
Jul 06 2007 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Sell | S | 12.33 | 100 | 1,233 | 48,030 | 48.1 K to 48 K (-0.21 %) |
Jul 06 2007 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Sell | S | 12.29 | 1,144 | 14,060 | 440,110 | 441.3 K to 440.1 K (-0.26 %) |
Jul 06 2007 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Sell | S | 12.30 | 2,962 | 36,433 | 441,254 | 444.2 K to 441.3 K (-0.67 %) |
Jul 06 2007 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Sell | S | 12.31 | 700 | 8,617 | 444,216 | 444.9 K to 444.2 K (-0.16 %) |
Jul 06 2007 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Sell | S | 12.32 | 504 | 6,209 | 444,916 | 445.4 K to 444.9 K (-0.11 %) |
Jul 06 2007 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Sell | S | 12.33 | 400 | 4,932 | 445,420 | 445.8 K to 445.4 K (-0.09 %) |
Jul 03 2007 | SLXP | SALIX PHARMACEUTIC ... | Forbes William P | V.P. Research& Deve ... | Grant | A | 0.00 | 13,845 | 0 | 27,345 | 13.5 K to 27.3 K (+102.56 %) |
Jul 03 2007 | SLXP | SALIX PHARMACEUTIC ... | KEANE WILLIAM P | Director | Grant | A | 0.00 | 9,230 | 0 | 21,230 | 12 K to 21.2 K (+76.92 %) |
Jul 03 2007 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Grant | A | 0.00 | 9,230 | 0 | 48,130 | 38.9 K to 48.1 K (+23.73 %) |
Jul 03 2007 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Grant | A | 0.00 | 71,540 | 0 | 445,820 | 374.3 K to 445.8 K (+19.11 %) |
Jul 03 2007 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Grant | A | 0.00 | 19,385 | 0 | 60,285 | 40.9 K to 60.3 K (+47.40 %) |
Jul 03 2007 | SLXP | SALIX PHARMACEUTIC ... | HARRAL WILLIAM III | Director | Grant | A | 0.00 | 9,230 | 0 | 37,704 | 28.5 K to 37.7 K (+32.42 %) |
Jul 03 2007 | SLXP | SALIX PHARMACEUTIC ... | FRANCO RICHARD A | Director | Grant | A | 0.00 | 9,230 | 0 | 39,330 | 30.1 K to 39.3 K (+30.66 %) |
Jul 03 2007 | SLXP | SALIX PHARMACEUTIC ... | CHAPPELL JOHN F | Director | Grant | A | 0.00 | 9,230 | 0 | 769,284 | 760.1 K to 769.3 K (+1.21 %) |
May 16 2007 | SLXP | SALIX PHARMACEUTIC ... | Reeth Mark D | Gen Counsel&VP Corp ... | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
Mar 08 2007 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Grant | A | 12.87 | 1,000 | 12,870 | 40,900 | 39.9 K to 40.9 K (+2.51 %) |
Jan 03 2007 | SLXP | SALIX PHARMACEUTIC ... | CHAPPELL JOHN F | Director | Gift | G | 0.00 | 25,000 | 0 | 760,054 | 785.1 K to 760.1 K (-3.18 %) |
Nov 22 2006 | SLXP | SALIX PHARMACEUTIC ... | FRANCO RICHARD A | Director | Buy | P | 14.21 | 5,100 | 72,471 | 30,100 | 25 K to 30.1 K (+20.40 %) |
Nov 17 2006 | SLXP | SALIX PHARMACEUTIC ... | FRANCO RICHARD A | Director | Option Exercise | M | 7.60 | 12,000 | 91,200 | 0 | |
Nov 17 2006 | SLXP | SALIX PHARMACEUTIC ... | FRANCO RICHARD A | Director | Sell | S | 13.69 | 12,000 | 164,280 | 25,000 | 37 K to 25 K (-32.43 %) |
Nov 17 2006 | SLXP | SALIX PHARMACEUTIC ... | FRANCO RICHARD A | Director | Buy | M | 7.60 | 12,000 | 91,200 | 37,000 | 25 K to 37 K (+48.00 %) |
Nov 15 2006 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Sell | S | 13.18 | 415 | 5,471 | 2,550 | 3 K to 2.6 K (-14.00 %) |
Nov 15 2006 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Sell | S | 13.18 | 485 | 6,392 | 2,965 | 3.5 K to 3 K (-14.06 %) |
Nov 15 2006 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Sell | S | 13.17 | 300 | 3,951 | 3,450 | 3.8 K to 3.5 K (-8.00 %) |
Oct 16 2006 | SLXP | SALIX PHARMACEUTIC ... | CHAPPELL JOHN F | Director | Gift | G | 0.00 | 20,000 | 0 | 785,054 | 805.1 K to 785.1 K (-2.48 %) |
Sep 05 2006 | SLXP | SALIX PHARMACEUTIC ... | CHAPPELL JOHN F | Director | Gift | G | 0.00 | 5,000 | 0 | 805,054 | 810.1 K to 805.1 K (-0.62 %) |
Sep 05 2006 | SLXP | SALIX PHARMACEUTIC ... | CHAPPELL JOHN F | Director | Gift | G | 0.00 | 15,000 | 0 | 810,054 | 825.1 K to 810.1 K (-1.82 %) |
Jul 17 2006 | SLXP | SALIX PHARMACEUTIC ... | KEANE WILLIAM P | Director | Grant | A | 0.00 | 10,000 | 0 | 12,000 | 2 K to 12 K (+500.00 %) |
Jul 17 2006 | SLXP | SALIX PHARMACEUTIC ... | HARRAL WILLIAM III | Director | Grant | A | 0.00 | 10,000 | 0 | 28,474 | 18.5 K to 28.5 K (+54.13 %) |
Jul 17 2006 | SLXP | SALIX PHARMACEUTIC ... | FRANCO RICHARD A | Director | Grant | A | 0.00 | 10,000 | 0 | 25,000 | 15 K to 25 K (+66.67 %) |
Jul 17 2006 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Grant | A | 0.00 | 10,000 | 0 | 38,900 | 28.9 K to 38.9 K (+34.60 %) |
Jul 17 2006 | SLXP | SALIX PHARMACEUTIC ... | CHAPPELL JOHN F | Chairman of the Boa ... | Grant | A | 0.00 | 10,000 | 0 | 825,054 | 815.1 K to 825.1 K (+1.23 %) |
Jul 17 2006 | SLXP | SALIX PHARMACEUTIC ... | Taylor David N MD | VP - Chief Medical ... | Grant | A | 0.00 | 13,500 | 0 | 13,500 | 0 to 13.5 K |
Jul 17 2006 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Grant | A | 0.00 | 69,750 | 0 | 374,280 | 304.5 K to 374.3 K (+22.90 %) |
Jul 17 2006 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Grant | A | 0.00 | 18,900 | 0 | 39,900 | 21 K to 39.9 K (+90.00 %) |
Jul 17 2006 | SLXP | SALIX PHARMACEUTIC ... | Forbes William P | V.P. Research& Deve ... | Grant | A | 0.00 | 13,500 | 0 | 13,500 | 0 to 13.5 K |
May 23 2006 | SLXP | SALIX PHARMACEUTIC ... | CHAPPELL JOHN F | Chairman of the Boa ... | Sell | J | 0.00 | 169,340 | 0 | 366,127 | 535.5 K to 366.1 K (-31.62 %) |
May 23 2006 | SLXP | SALIX PHARMACEUTIC ... | CHAPPELL JOHN F | Chairman of the Boa ... | Buy | J | 0.00 | 169,340 | 0 | 815,054 | 645.7 K to 815.1 K (+26.23 %) |
May 22 2006 | SLXP | SALIX PHARMACEUTIC ... | HARRAL WILLIAM III | Director | Buy | P | 12.35 | 2,190 | 27,047 | 18,474 | 16.3 K to 18.5 K (+13.45 %) |
May 22 2006 | SLXP | SALIX PHARMACEUTIC ... | HARRAL WILLIAM III | Director | Buy | P | 12.34 | 2,810 | 34,675 | 16,284 | 13.5 K to 16.3 K (+20.85 %) |
May 10 2006 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 13.01 | 5,000 | 65,050 | 6,500 | 1.5 K to 6.5 K (+333.33 %) |
May 10 2006 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 13.03 | 1,000 | 13,026 | 10,250 | 9.3 K to 10.3 K (+10.81 %) |
May 10 2006 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 13.01 | 900 | 11,709 | 28,900 | 28 K to 28.9 K (+3.21 %) |
May 10 2006 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Buy | P | 13.23 | 7,500 | 99,239 | 304,530 | 297 K to 304.5 K (+2.52 %) |
Mar 13 2006 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Option Exercise | M | 1.13 | 30,000 | 33,900 | 150,000 | |
Mar 13 2006 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Buy | M | 1.13 | 30,000 | 33,900 | 297,030 | 267 K to 297 K (+11.23 %) |
Mar 13 2006 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Gift | G | 0.00 | 1,500 | 0 | 267,030 | 268.5 K to 267 K (-0.56 %) |
Mar 01 2006 | SLXP | SALIX PHARMACEUTIC ... | KEANE WILLIAM P | Director | Grant | A | 15.95 | 2,000 | 31,898 | 2,000 | 0 to 2 K |
Mar 01 2006 | SLXP | SALIX PHARMACEUTIC ... | HARRAL WILLIAM III | Director | Grant | A | 16.24 | 10,000 | 162,449 | 13,474 | 3.5 K to 13.5 K (+287.85 %) |
Nov 14 2005 | SLXP | SALIX PHARMACEUTIC ... | CHAPPELL JOHN F | Chairman of the Boa ... | Sell | S | 19.24 | 10,000 | 192,400 | 555,803 | 565.8 K to 555.8 K (-1.77 %) |
Jun 13 2005 | SLXP | SALIX PHARMACEUTIC ... | Taylor David N MD | VP - Chief Medical ... | Option Exercise | A | 17.63 | 10,500 | 185,115 | 10,500 | |
Jun 13 2005 | SLXP | SALIX PHARMACEUTIC ... | KEANE WILLIAM P | Director | Option Exercise | A | 17.63 | 15,000 | 264,450 | 15,000 | |
Jun 13 2005 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | Sr. VP Finance/CFO | Option Exercise | A | 17.63 | 20,000 | 352,600 | 20,000 | |
Jun 13 2005 | SLXP | SALIX PHARMACEUTIC ... | Forbes William P | V.P. Research& Deve ... | Option Exercise | A | 17.63 | 6,250 | 110,188 | 6,250 | |
Jun 13 2005 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Gift | G | 0.00 | 1,450 | 0 | 179,450 | 180.9 K to 179.5 K (-0.80 %) |
Jun 13 2005 | SLXP | SALIX PHARMACEUTIC ... | FRANCO RICHARD A | Director | Option Exercise | A | 17.63 | 15,000 | 264,450 | 15,000 | |
Jun 13 2005 | SLXP | SALIX PHARMACEUTIC ... | CELESTINI STEPHEN D | Gen Coun & Vice Pre ... | Option Exercise | A | 17.63 | 12,500 | 220,375 | 12,500 | |
Jun 13 2005 | SLXP | SALIX PHARMACEUTIC ... | CHAPPELL JOHN F | Chairman of the Boa ... | Option Exercise | A | 17.63 | 15,000 | 264,450 | 15,000 | |
Jun 13 2005 | SLXP | SALIX PHARMACEUTIC ... | CHAPPELL JOHN F | Chairman of the Boa ... | Gift | G | 0.00 | 12,000 | 0 | 565,803 | 577.8 K to 565.8 K (-2.08 %) |
Jun 13 2005 | SLXP | SALIX PHARMACEUTIC ... | CHAPPELL JOHN F | Chairman of the Boa ... | Gift | G | 0.00 | 6,500 | 0 | 577,803 | 584.3 K to 577.8 K (-1.11 %) |
Jun 13 2005 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Option Exercise | A | 17.63 | 15,000 | 264,450 | 15,000 | |
May 25 2005 | SLXP | SALIX PHARMACEUTIC ... | CHAPPELL JOHN F | Chairman of the Boa ... | Sell | D | 0.00 | 136,605 | 0 | 214,951 | 351.6 K to 215 K (-38.86 %) |
May 25 2005 | SLXP | SALIX PHARMACEUTIC ... | CHAPPELL JOHN F | Chairman of the Boa ... | Grant | A | 0.00 | 136,605 | 0 | 584,303 | 447.7 K to 584.3 K (+30.51 %) |
Mar 04 2005 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Gift | G | 0.00 | 1,370 | 0 | 178,080 | 179.5 K to 178.1 K (-0.76 %) |
Nov 30 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 15.15 | 1,000 | 15,150 | 9,250 | 8.3 K to 9.3 K (+12.12 %) |
Nov 30 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 15.17 | 2,900 | 43,993 | 8,250 | 5.4 K to 8.3 K (+54.21 %) |
Nov 30 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 15.15 | 100 | 1,515 | 5,350 | 5.3 K to 5.4 K (+1.90 %) |
Nov 30 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 15.24 | 200 | 3,048 | 11,750 | 11.6 K to 11.8 K (+1.73 %) |
Nov 30 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 15.26 | 200 | 3,052 | 11,550 | 11.4 K to 11.6 K (+1.76 %) |
Nov 30 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 15.27 | 300 | 4,581 | 11,350 | 11.1 K to 11.4 K (+2.71 %) |
Nov 30 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 15.28 | 100 | 1,528 | 11,050 | 11 K to 11.1 K (+0.91 %) |
Nov 30 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 15.29 | 1,200 | 18,348 | 10,950 | 9.8 K to 11 K (+12.31 %) |
Nov 30 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 15.17 | 2,553 | 38,729 | 9,750 | 7.2 K to 9.8 K (+35.47 %) |
Nov 30 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 15.16 | 447 | 6,777 | 7,197 | 6.8 K to 7.2 K (+6.62 %) |
Nov 30 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 15.15 | 1,000 | 15,150 | 28,000 | 27 K to 28 K (+3.70 %) |
Nov 30 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 15.18 | 400 | 6,072 | 27,000 | 26.6 K to 27 K (+1.50 %) |
Nov 30 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 15.20 | 200 | 3,040 | 26,600 | 26.4 K to 26.6 K (+0.76 %) |
Nov 30 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 15.21 | 100 | 1,521 | 26,400 | 26.3 K to 26.4 K (+0.38 %) |
Nov 30 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 15.22 | 100 | 1,522 | 26,300 | 26.2 K to 26.3 K (+0.38 %) |
Nov 30 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 15.23 | 300 | 4,569 | 26,200 | 25.9 K to 26.2 K (+1.16 %) |
Nov 30 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 15.25 | 900 | 13,725 | 25,900 | 25 K to 25.9 K (+3.60 %) |
Nov 30 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 15.23 | 2,452 | 37,344 | 25,000 | 22.5 K to 25 K (+10.87 %) |
Nov 30 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 15.22 | 548 | 8,341 | 22,548 | 22 K to 22.5 K (+2.49 %) |
Nov 30 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 15.21 | 300 | 4,563 | 22,000 | 21.7 K to 22 K (+1.38 %) |
Nov 30 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 15.19 | 600 | 9,114 | 21,700 | 21.1 K to 21.7 K (+2.84 %) |
Nov 30 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 15.16 | 100 | 1,516 | 21,100 | 21 K to 21.1 K (+0.48 %) |
Nov 03 2004 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Gift | G | 0.00 | 1,450 | 0 | 179,450 | 180.9 K to 179.5 K (-0.80 %) |
Jul 07 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Option Exercise | A | 28.31 | 15,000 | 424,650 | 15,000 | |
Jul 07 2004 | SLXP | SALIX PHARMACEUTIC ... | FRANCO RICHARD A | Director | Option Exercise | A | 28.31 | 15,000 | 424,650 | 15,000 | |
Jul 07 2004 | SLXP | SALIX PHARMACEUTIC ... | CHAPPELL JOHN F | Director | Option Exercise | A | 28.31 | 15,000 | 424,650 | 15,000 | |
Jul 07 2004 | SLXP | SALIX PHARMACEUTIC ... | KEANE WILLIAM P | Director | Option Exercise | A | 28.31 | 15,000 | 424,650 | 15,000 | |
Jul 07 2004 | SLXP | SALIX PHARMACEUTIC ... | KEANE WILLIAM P | Director | Option Exercise | A | 28.31 | 15,000 | 424,650 | 15,000 | |
Jul 07 2004 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Option Exercise | A | 28.31 | 43,750 | 1,238,563 | 43,750 | |
Jul 07 2004 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Option Exercise | A | 28.31 | 22,500 | 636,975 | 22,500 | |
Jul 07 2004 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | VP Finance/CFO | Option Exercise | A | 28.31 | 20,000 | 566,200 | 20,000 | |
Jul 07 2004 | SLXP | SALIX PHARMACEUTIC ... | CELESTINI STEPHEN D | Gen Coun & Vice Pre ... | Option Exercise | A | 28.31 | 25,000 | 707,750 | 25,000 | |
Jul 07 2004 | SLXP | SALIX PHARMACEUTIC ... | CELESTINI STEPHEN D | Gen Coun & Vice Pre ... | Option Exercise | A | 28.31 | 6,000 | 169,860 | 6,000 | |
Jul 02 2004 | SLXP | SALIX PHARMACEUTIC ... | CHAPPELL JOHN F | Director | Gift | G | 0.00 | 350 | 0 | 447,698 | 448 K to 447.7 K (-0.08 %) |
Jun 07 2004 | SLXP | SALIX PHARMACEUTIC ... | CHAPPELL JOHN F | Director | Gift | G | 0.00 | 51,952 | 0 | 351,556 | 299.6 K to 351.6 K (+17.34 %) |
Jun 07 2004 | SLXP | SALIX PHARMACEUTIC ... | CHAPPELL JOHN F | Director | Gift | G | 0.00 | 51,952 | 0 | 448,048 | 500 K to 448 K (-10.39 %) |
Mar 03 2004 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Option Exercise | M | 1.70 | 20,000 | 34,000 | 120,000 | |
Mar 03 2004 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Buy | M | 1.70 | 20,000 | 34,000 | 20,000 | 0 to 20 K |
Mar 01 2004 | SLXP | SALIX PHARMACEUTIC ... | FRANCO RICHARD A | Director | Sell | S | 26.65 | 1,650 | 43,973 | 10,000 | 11.7 K to 10 K (-14.16 %) |
Feb 26 2004 | SLXP | SALIX PHARMACEUTIC ... | CHAPPELL JOHN F | Director | Gift | G | 0.00 | 1,095 | 0 | 804,604 | 805.7 K to 804.6 K (-0.14 %) |
Feb 13 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Sell | S | 27.93 | 3,000 | 83,790 | 3,500 | 6.5 K to 3.5 K (-46.15 %) |
Feb 13 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 9.72 | 500 | 4,860 | 6,500 | 6 K to 6.5 K (+8.33 %) |
Feb 13 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 7.00 | 4,000 | 28,000 | 6,000 | 2 K to 6 K (+200.00 %) |
Feb 13 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 1.73 | 2,000 | 3,460 | 2,000 | 0 to 2 K |
Feb 13 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Sell | S | 26.50 | 3,100 | 82,150 | 4,000 | 7.1 K to 4 K (-43.66 %) |
Feb 13 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Sell | S | 26.54 | 200 | 5,308 | 7,100 | 7.3 K to 7.1 K (-2.74 %) |
Feb 13 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Sell | S | 26.56 | 700 | 18,592 | 7,300 | 8 K to 7.3 K (-8.75 %) |
Feb 13 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 7.02 | 6,000 | 42,120 | 8,000 | 2 K to 8 K (+300.00 %) |
Feb 13 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 1.73 | 2,000 | 3,460 | 2,000 | 0 to 2 K |
Feb 13 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Sell | S | 26.66 | 100 | 2,666 | 4,500 | 4.6 K to 4.5 K (-2.17 %) |
Feb 13 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Sell | S | 26.65 | 100 | 2,665 | 4,600 | 4.7 K to 4.6 K (-2.13 %) |
Feb 13 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Sell | S | 26.60 | 100 | 2,660 | 4,700 | 4.8 K to 4.7 K (-2.08 %) |
Feb 13 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Sell | S | 26.55 | 200 | 5,310 | 4,800 | 5 K to 4.8 K (-4.00 %) |
Feb 13 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Sell | S | 26.54 | 3,500 | 92,890 | 5,000 | 8.5 K to 5 K (-41.18 %) |
Feb 13 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 7.03 | 6,000 | 42,180 | 8,500 | 2.5 K to 8.5 K (+240.00 %) |
Feb 13 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 13.75 | 500 | 6,875 | 2,500 | 2 K to 2.5 K (+25.00 %) |
Feb 13 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 1.73 | 2,000 | 3,460 | 2,000 | 0 to 2 K |
Feb 13 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Sell | S | 26.60 | 2,500 | 66,500 | 2,500 | 5 K to 2.5 K (-50.00 %) |
Feb 13 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 8.40 | 1,000 | 8,400 | 5,000 | 4 K to 5 K (+25.00 %) |
Feb 13 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 7.02 | 4,000 | 28,080 | 4,000 | 0 to 4 K |
Feb 13 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Sell | S | 26.60 | 4,000 | 106,400 | 14,000 | 18 K to 14 K (-22.22 %) |
Feb 13 2004 | SLXP | SALIX PHARMACEUTIC ... | D ALONZO THOMAS | Director | Buy | P | 7.03 | 8,000 | 56,240 | 18,000 | 10 K to 18 K (+80.00 %) |
Feb 10 2004 | SLXP | SALIX PHARMACEUTIC ... | FRANCO RICHARD A | Director | Option Exercise | M | 7.38 | 15,000 | 110,700 | 0 | |
Feb 10 2004 | SLXP | SALIX PHARMACEUTIC ... | FRANCO RICHARD A | Director | Option Exercise | M | 6.10 | 10,000 | 61,000 | 0 | |
Feb 10 2004 | SLXP | SALIX PHARMACEUTIC ... | FRANCO RICHARD A | Director | Option Exercise | M | 11.40 | 2,000 | 22,800 | 8,000 | |
Feb 10 2004 | SLXP | SALIX PHARMACEUTIC ... | FRANCO RICHARD A | Director | Sell | S | 26.32 | 27,000 | 710,640 | 11,650 | 38.7 K to 11.7 K (-69.86 %) |
Feb 10 2004 | SLXP | SALIX PHARMACEUTIC ... | FRANCO RICHARD A | Director | Buy | M | 7.38 | 15,000 | 110,700 | 38,650 | 23.7 K to 38.7 K (+63.42 %) |
Feb 10 2004 | SLXP | SALIX PHARMACEUTIC ... | FRANCO RICHARD A | Director | Buy | M | 6.10 | 10,000 | 61,000 | 23,650 | 13.7 K to 23.7 K (+73.26 %) |
Feb 10 2004 | SLXP | SALIX PHARMACEUTIC ... | FRANCO RICHARD A | Director | Buy | M | 11.40 | 2,000 | 22,800 | 13,650 | 11.7 K to 13.7 K (+17.17 %) |